ClearPath DS-120 Clinical Study Protocol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01425346|
Recruitment Status : Completed
First Posted : August 30, 2011
Last Update Posted : August 30, 2011
|Condition or disease|
|Ophthalmic, Healthy Eyes|
|Study Type :||Observational|
|Actual Enrollment :||128 participants|
|Official Title:||Freedom Meditech ClearPath DS-120 Clinical Study Protocol FM2-002-CTP|
|Study Start Date :||June 2011|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||July 2011|
Normal, healthy males and females between the ages of 21 and 70 with healthy eyes as determined by a standard ophthalmic examination.
- Lens fluorescence [ Time Frame: Day 1 ]evaluate the ability of the ClearPath DS-120 instrument to measure the fluorescence and scattering responses of the human crystalline lens in a normal subject population with healthy eyes (as determined by standard comprehensive ophthalmic examination).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01425346
|United States, California|
|San Diego Optometry Practice|
|San Diego, California, United States, 92122|
|Principal Investigator:||Stephen W. Lum, O.D.||San Diego Optometry Practice|